Circulating microRNA profiling identifies microRNAs linked to prediabetes associated with alcohol dependence syndrome
Palaniswamy Ramaswamy1, Athira S V2, Pratibha Misra2
1Multi Disciplinary Research Unit, Armed Forces Medical College, Pune, India, 411040.
Alcohol (Fayetteville, N.Y.)
|January 24, 2024
Summary
Serum microRNAs (miRNAs) differ in patients with alcohol dependence syndrome (ADS) and prediabetes. Researchers identified hsa-miR-320b and hsa-miR-3135b as potential biomarkers for diagnosing prediabetes in ADS patients.
Area of Science:
- Biochemistry
- Genetics
- Endocrinology
Background:
- MicroRNAs are key gene regulators found in serum, linked to various diseases.
- Alcohol dependence syndrome (ADS) and prediabetes represent significant health concerns.
Purpose of the Study:
- To identify and confirm serum microRNAs (miRNAs) associated with prediabetes in individuals with alcohol dependence syndrome (ADS).
Main Methods:
- Microarray analysis of serum samples from ADS patients (with/without prediabetes) and controls.
- Validation of candidate miRNAs using reverse transcription quantitative polymerase chain reaction (RT-qPCR).
- Gene Ontology (GO) and KEGG pathway analyses to predict miRNA target genes.
Main Results:
- Significant differential expression of 198 and 172 miRNAs in ADS patients with/without prediabetes versus controls.
- Seven miRNAs were uniquely altered in prediabetic ADS patients compared to non-diabetic ADS patients.
- Serum hsa-miR-320b and hsa-miR-3135b were exclusively differentially expressed in prediabetic ADS patients and validated.
- Pathway analysis indicated enrichment of diabetes-related biological processes and pathways.
Conclusions:
- Individuals with ADS, with or without prediabetes, exhibit distinct serum miRNA profiles compared to healthy individuals.
- Serum hsa-miR-320b and hsa-miR-3135b show promise as diagnostic biomarkers for prediabetes in the context of ADS.


